comparemela.com

Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FSHD Society is deploying powerful AI technology to improve clinical trial design for facioscapulohumeral muscular dystrophy

Randolph, Massachusetts (PRWEB) April 21, 2022 The FSHD Society announced that it is launching a collaboration involving the FSHD Clinical Trial Research

United statesUnited kingdomRabi tawilRvin singhJeffrey statlandJamshid arjomandFacioscapulohumeral muscular dystrophy clinical trial research networkUniversity of kansas medical centerJohns hopkins university applied physics laboratoryClinical trial research networkUniversity of rochesterTrial research networkArtificial intelligenceClinical trial readinessSolve barriersDrug development

Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomMark stoneKath gallagherCherise adkinsJeffrey statlandSarah boyceMuscular dystrophy associationUniversity of kansas medical centerFacioscapulohumeral muscular dystrophy clinical trial research networkDepartment of neurologyPrnewswire avidity biosciences incExchange commissionCompany investors contactClinical trial research networkClinical research centers

vimarsana © 2020. All Rights Reserved.